Indian pharma firms may gain market share due to higher US tariffs: Report
Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan report.
Read MoreIndian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan report.
Read MoreFinance Minister Nirmala Sitharaman emphasized that India’s process of reducing customs duties and eliminating the equalization levy is ongoing and independent of global events. Simultaneously, President Trump announced a significant 25% tariff on all imported vehicles to boost domestic manufacturing,…
Read MoreIndians in 2024 collectively spent 1.1 trillion hours on their smartphones, primarily on social media, gaming, and videos, driving digital channels to overtake traditional media in the entertainment industry. With 5G adoption soaring, India remains the largest market for mobile…
Read MoreGlobal HR company Deel said the demand for AI talent in India is expected to more than double from 600,000 in 2022 to over 1,250,000 by 2027. Recruitment tech firm Supersourcing said it has worked with 35 AI startups and…
Read MoreSebi has tasked a high-level committee to suggest a fresh framework for managing conflicts of interest, and disclosure related matters in order to ensure transparency, accountability, and ethical conduct of Members and Officials of the Board.
Read MoreWhen it comes to the ratio of goods exports to GDP in the wake of US trade tariffs, India and Japan are the least exposed economies owing to domestic demand strength, a Morgan Stanley report said on Friday.
Read More